Androgen Receptor (AR) Inhibitor Market, Global Outlook and Forecast 2022-2028

June 2022 | 60 pages | ID: A832F08A3FDDEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Androgen Receptor (AR) Inhibitor in Global, including the following market information:

Global Androgen Receptor (AR) Inhibitor Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Androgen Receptor (AR) Inhibitor market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Steroids Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Androgen Receptor (AR) Inhibitor include Orion Corporation, Pfizer, Hengrui, Bayer, Schering-Plough and Hinova Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Androgen Receptor (AR) Inhibitor companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Androgen Receptor (AR) Inhibitor Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Androgen Receptor (AR) Inhibitor Market Segment Percentages, by Type, 2021 (%)

• Steroids
• Nonsteroidal

Global Androgen Receptor (AR) Inhibitor Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Androgen Receptor (AR) Inhibitor Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinic
• Others

Global Androgen Receptor (AR) Inhibitor Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Androgen Receptor (AR) Inhibitor Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Androgen Receptor (AR) Inhibitor revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Androgen Receptor (AR) Inhibitor revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Orion Corporation
• Pfizer
• Hengrui
• Bayer
• Schering-Plough
• Hinova Pharma

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Androgen Receptor (AR) Inhibitor Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Androgen Receptor (AR) Inhibitor Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ANDROGEN RECEPTOR (AR) INHIBITOR OVERALL MARKET SIZE

2.1 Global Androgen Receptor (AR) Inhibitor Market Size: 2021 VS 2028
2.2 Global Androgen Receptor (AR) Inhibitor Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Androgen Receptor (AR) Inhibitor Players in Global Market
3.2 Top Global Androgen Receptor (AR) Inhibitor Companies Ranked by Revenue
3.3 Global Androgen Receptor (AR) Inhibitor Revenue by Companies
3.4 Top 3 and Top 5 Androgen Receptor (AR) Inhibitor Companies in Global Market, by Revenue in 2021
3.5 Global Companies Androgen Receptor (AR) Inhibitor Product Type
3.6 Tier 1, Tier 2 and Tier 3 Androgen Receptor (AR) Inhibitor Players in Global Market
  3.6.1 List of Global Tier 1 Androgen Receptor (AR) Inhibitor Companies
  3.6.2 List of Global Tier 2 and Tier 3 Androgen Receptor (AR) Inhibitor Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Androgen Receptor (AR) Inhibitor Market Size Markets, 2021 & 2028
  4.1.2 Steroids
  4.1.3 Nonsteroidal
4.2 By Type - Global Androgen Receptor (AR) Inhibitor Revenue & Forecasts
  4.2.1 By Type - Global Androgen Receptor (AR) Inhibitor Revenue, 2017-2022
  4.2.2 By Type - Global Androgen Receptor (AR) Inhibitor Revenue, 2023-2028
  4.2.3 By Type - Global Androgen Receptor (AR) Inhibitor Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Androgen Receptor (AR) Inhibitor Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Clinic
  5.1.4 Others
5.2 By Application - Global Androgen Receptor (AR) Inhibitor Revenue & Forecasts
  5.2.1 By Application - Global Androgen Receptor (AR) Inhibitor Revenue, 2017-2022
  5.2.2 By Application - Global Androgen Receptor (AR) Inhibitor Revenue, 2023-2028
  5.2.3 By Application - Global Androgen Receptor (AR) Inhibitor Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Androgen Receptor (AR) Inhibitor Market Size, 2021 & 2028
6.2 By Region - Global Androgen Receptor (AR) Inhibitor Revenue & Forecasts
  6.2.1 By Region - Global Androgen Receptor (AR) Inhibitor Revenue, 2017-2022
  6.2.2 By Region - Global Androgen Receptor (AR) Inhibitor Revenue, 2023-2028
  6.2.3 By Region - Global Androgen Receptor (AR) Inhibitor Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Androgen Receptor (AR) Inhibitor Revenue, 2017-2028
  6.3.2 US Androgen Receptor (AR) Inhibitor Market Size, 2017-2028
  6.3.3 Canada Androgen Receptor (AR) Inhibitor Market Size, 2017-2028
  6.3.4 Mexico Androgen Receptor (AR) Inhibitor Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Androgen Receptor (AR) Inhibitor Revenue, 2017-2028
  6.4.2 Germany Androgen Receptor (AR) Inhibitor Market Size, 2017-2028
  6.4.3 France Androgen Receptor (AR) Inhibitor Market Size, 2017-2028
  6.4.4 U.K. Androgen Receptor (AR) Inhibitor Market Size, 2017-2028
  6.4.5 Italy Androgen Receptor (AR) Inhibitor Market Size, 2017-2028
  6.4.6 Russia Androgen Receptor (AR) Inhibitor Market Size, 2017-2028
  6.4.7 Nordic Countries Androgen Receptor (AR) Inhibitor Market Size, 2017-2028
  6.4.8 Benelux Androgen Receptor (AR) Inhibitor Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Androgen Receptor (AR) Inhibitor Revenue, 2017-2028
  6.5.2 China Androgen Receptor (AR) Inhibitor Market Size, 2017-2028
  6.5.3 Japan Androgen Receptor (AR) Inhibitor Market Size, 2017-2028
  6.5.4 South Korea Androgen Receptor (AR) Inhibitor Market Size, 2017-2028
  6.5.5 Southeast Asia Androgen Receptor (AR) Inhibitor Market Size, 2017-2028
  6.5.6 India Androgen Receptor (AR) Inhibitor Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Androgen Receptor (AR) Inhibitor Revenue, 2017-2028
  6.6.2 Brazil Androgen Receptor (AR) Inhibitor Market Size, 2017-2028
  6.6.3 Argentina Androgen Receptor (AR) Inhibitor Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Androgen Receptor (AR) Inhibitor Revenue, 2017-2028
  6.7.2 Turkey Androgen Receptor (AR) Inhibitor Market Size, 2017-2028
  6.7.3 Israel Androgen Receptor (AR) Inhibitor Market Size, 2017-2028
  6.7.4 Saudi Arabia Androgen Receptor (AR) Inhibitor Market Size, 2017-2028
  6.7.5 UAE Androgen Receptor (AR) Inhibitor Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Orion Corporation
  7.1.1 Orion Corporation Corporate Summary
  7.1.2 Orion Corporation Business Overview
  7.1.3 Orion Corporation Androgen Receptor (AR) Inhibitor Major Product Offerings
  7.1.4 Orion Corporation Androgen Receptor (AR) Inhibitor Revenue in Global Market (2017-2022)
  7.1.5 Orion Corporation Key News
7.2 Pfizer
  7.2.1 Pfizer Corporate Summary
  7.2.2 Pfizer Business Overview
  7.2.3 Pfizer Androgen Receptor (AR) Inhibitor Major Product Offerings
  7.2.4 Pfizer Androgen Receptor (AR) Inhibitor Revenue in Global Market (2017-2022)
  7.2.5 Pfizer Key News
7.3 Hengrui
  7.3.1 Hengrui Corporate Summary
  7.3.2 Hengrui Business Overview
  7.3.3 Hengrui Androgen Receptor (AR) Inhibitor Major Product Offerings
  7.3.4 Hengrui Androgen Receptor (AR) Inhibitor Revenue in Global Market (2017-2022)
  7.3.5 Hengrui Key News
7.4 Bayer
  7.4.1 Bayer Corporate Summary
  7.4.2 Bayer Business Overview
  7.4.3 Bayer Androgen Receptor (AR) Inhibitor Major Product Offerings
  7.4.4 Bayer Androgen Receptor (AR) Inhibitor Revenue in Global Market (2017-2022)
  7.4.5 Bayer Key News
7.5 Schering-Plough
  7.5.1 Schering-Plough Corporate Summary
  7.5.2 Schering-Plough Business Overview
  7.5.3 Schering-Plough Androgen Receptor (AR) Inhibitor Major Product Offerings
  7.5.4 Schering-Plough Androgen Receptor (AR) Inhibitor Revenue in Global Market (2017-2022)
  7.5.5 Schering-Plough Key News
7.6 Hinova Pharma
  7.6.1 Hinova Pharma Corporate Summary
  7.6.2 Hinova Pharma Business Overview
  7.6.3 Hinova Pharma Androgen Receptor (AR) Inhibitor Major Product Offerings
  7.6.4 Hinova Pharma Androgen Receptor (AR) Inhibitor Revenue in Global Market (2017-2022)
  7.6.5 Hinova Pharma Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Androgen Receptor (AR) Inhibitor Market Opportunities & Trends in Global Market
Table 2. Androgen Receptor (AR) Inhibitor Market Drivers in Global Market
Table 3. Androgen Receptor (AR) Inhibitor Market Restraints in Global Market
Table 4. Key Players of Androgen Receptor (AR) Inhibitor in Global Market
Table 5. Top Androgen Receptor (AR) Inhibitor Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Androgen Receptor (AR) Inhibitor Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Androgen Receptor (AR) Inhibitor Revenue Share by Companies, 2017-2022
Table 8. Global Companies Androgen Receptor (AR) Inhibitor Product Type
Table 9. List of Global Tier 1 Androgen Receptor (AR) Inhibitor Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Androgen Receptor (AR) Inhibitor Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Androgen Receptor (AR) Inhibitor Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Androgen Receptor (AR) Inhibitor Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Androgen Receptor (AR) Inhibitor Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Androgen Receptor (AR) Inhibitor Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Androgen Receptor (AR) Inhibitor Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Androgen Receptor (AR) Inhibitor Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Androgen Receptor (AR) Inhibitor Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Androgen Receptor (AR) Inhibitor Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Androgen Receptor (AR) Inhibitor Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Androgen Receptor (AR) Inhibitor Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Androgen Receptor (AR) Inhibitor Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Androgen Receptor (AR) Inhibitor Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Androgen Receptor (AR) Inhibitor Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Androgen Receptor (AR) Inhibitor Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Androgen Receptor (AR) Inhibitor Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Androgen Receptor (AR) Inhibitor Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Androgen Receptor (AR) Inhibitor Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Androgen Receptor (AR) Inhibitor Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Androgen Receptor (AR) Inhibitor Revenue, (US$, Mn), 2023-2028
Table 30. Orion Corporation Corporate Summary
Table 31. Orion Corporation Androgen Receptor (AR) Inhibitor Product Offerings
Table 32. Orion Corporation Androgen Receptor (AR) Inhibitor Revenue (US$, Mn), (2017-2022)
Table 33. Pfizer Corporate Summary
Table 34. Pfizer Androgen Receptor (AR) Inhibitor Product Offerings
Table 35. Pfizer Androgen Receptor (AR) Inhibitor Revenue (US$, Mn), (2017-2022)
Table 36. Hengrui Corporate Summary
Table 37. Hengrui Androgen Receptor (AR) Inhibitor Product Offerings
Table 38. Hengrui Androgen Receptor (AR) Inhibitor Revenue (US$, Mn), (2017-2022)
Table 39. Bayer Corporate Summary
Table 40. Bayer Androgen Receptor (AR) Inhibitor Product Offerings
Table 41. Bayer Androgen Receptor (AR) Inhibitor Revenue (US$, Mn), (2017-2022)
Table 42. Schering-Plough Corporate Summary
Table 43. Schering-Plough Androgen Receptor (AR) Inhibitor Product Offerings
Table 44. Schering-Plough Androgen Receptor (AR) Inhibitor Revenue (US$, Mn), (2017-2022)
Table 45. Hinova Pharma Corporate Summary
Table 46. Hinova Pharma Androgen Receptor (AR) Inhibitor Product Offerings
Table 47. Hinova Pharma Androgen Receptor (AR) Inhibitor Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Androgen Receptor (AR) Inhibitor Segment by Type in 2021
Figure 2. Androgen Receptor (AR) Inhibitor Segment by Application in 2021
Figure 3. Global Androgen Receptor (AR) Inhibitor Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Androgen Receptor (AR) Inhibitor Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Androgen Receptor (AR) Inhibitor Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Androgen Receptor (AR) Inhibitor Revenue in 2021
Figure 8. By Type - Global Androgen Receptor (AR) Inhibitor Revenue Market Share, 2017-2028
Figure 9. By Application - Global Androgen Receptor (AR) Inhibitor Revenue Market Share, 2017-2028
Figure 10. By Region - Global Androgen Receptor (AR) Inhibitor Revenue Market Share, 2017-2028
Figure 11. By Country - North America Androgen Receptor (AR) Inhibitor Revenue Market Share, 2017-2028
Figure 12. US Androgen Receptor (AR) Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Androgen Receptor (AR) Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Androgen Receptor (AR) Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Androgen Receptor (AR) Inhibitor Revenue Market Share, 2017-2028
Figure 16. Germany Androgen Receptor (AR) Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 17. France Androgen Receptor (AR) Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Androgen Receptor (AR) Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Androgen Receptor (AR) Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Androgen Receptor (AR) Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Androgen Receptor (AR) Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Androgen Receptor (AR) Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Androgen Receptor (AR) Inhibitor Revenue Market Share, 2017-2028
Figure 24. China Androgen Receptor (AR) Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Androgen Receptor (AR) Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Androgen Receptor (AR) Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Androgen Receptor (AR) Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 28. India Androgen Receptor (AR) Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Androgen Receptor (AR) Inhibitor Revenue Market Share, 2017-2028
Figure 30. Brazil Androgen Receptor (AR) Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Androgen Receptor (AR) Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Androgen Receptor (AR) Inhibitor Revenue Market Share, 2017-2028
Figure 33. Turkey Androgen Receptor (AR) Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Androgen Receptor (AR) Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Androgen Receptor (AR) Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Androgen Receptor (AR) Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 37. Orion Corporation Androgen Receptor (AR) Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Pfizer Androgen Receptor (AR) Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Hengrui Androgen Receptor (AR) Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Bayer Androgen Receptor (AR) Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Schering-Plough Androgen Receptor (AR) Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Hinova Pharma Androgen Receptor (AR) Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)